Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
70.90
+1.30 (1.87%)
At close: May 24, 2026
41.80% (1Y)
| Market Cap | 7.62B +28.0% |
| Revenue (ttm) | 10.07B +26.3% |
| Net Income | 609.04M +44.4% |
| EPS | 5.65 +43.8% |
| Shares Out | 107.42M |
| PE Ratio | 12.56 |
| Forward PE | n/a |
| Dividend | 1.40 (1.97%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 1,374,712 |
| Open | 70.50 |
| Previous Close | 69.60 |
| Day's Range | 68.60 - 71.70 |
| 52-Week Range | 45.50 - 72.80 |
| Beta | 0.06 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 28, 2026 |